SBRANasdaqReal Estate Investment TrustsFiscal year ends December 31
Sabra Health Care REIT, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$19.08−0.26 (-1.34%)
Close on Oct 19, 2026
- Market cap
- $4.81B
- P/E (TTM)
- 73.4
- Dividend yield
- 6.29%
Share price
+$0.95 (+5.24%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsEx-dividend
Sabra Health Care REIT, Inc. grew revenue 17.3% to $859.56M over the twelve months to Jun 30, 2026.
Revenue
$859.56M
+17.3% vs. a year earlier
EPS, diluted
$0.26
-65.8% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $4.81B
- P/E ratio
- 73.4
- Price to sales
- 5.60
- Price to book
- 1.75
- Dividend yield
- 6.29%
- Free cash flow yield
- –
Fundamentals
- Revenue
- $859.56M
- Net income
- $65.44M
- EPS, diluted
- $0.26
- Book value per share
- $10.90
- Diluted shares
- 252M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$859.56M+17.3% YoY
Net income
$65.44M-64.1% YoY
EPS, diluted
$0.26-65.8% YoY
Reported periodTrailing twelve months